INVESTOR ALERT: Investigation of Trex Company, Inc. (TREX) Announced by Holzer & Holzer, LLC

Impact · against what's priced in

Trex faces negative pressure from a combination of missed sales targets and a production cut to clear channel inventory, which is now being followed by a legal investigation. Grace Therapeutics and Fulcrum Therapeutics are facing separate securities law investigations, introducing new regulatory and legal risk.

TREX−0.50

No priced-in read yet